Renal effects of dexmedetomidine during coronary artery bypass surgery: A randomized placebo-controlled study

Dexmedetomidine, an alpha2-adrenoceptor agonist, has been evaluated as an adjunct to anesthesia and for the delivery of sedation and perioperative hemodynamic stability. It provokes dose-dependent and centrally-mediated sympatholysis.